Multifocal choroiditis and panuveitis
 | This article needs more photopsias, enlargement of the physiologic blind spot and decreased vision.[citation needed ]
The first description of the disease was written in 1973.[1] SymptomsSymptoms include blurry vision, with or without sensitivity to light, blind spots, floaters, eye discomfort and perceived flashes of light.[1] DiagnosisAn ophthalmologist may use a series of imaging techniques. A test called flourescein angiography uses a special dye and camera to study blood flow in the back layers of the eye.
When a person has multifocal choroiditis (MFC), lesions in the eye will appear as fluorescent spots. Visual field tests may also show an enlarged blind spot or a decrease in visual clarity. Often, doctors may order blood tests to check if the symptoms are caused by a viral disease rather than MFC.
TreatmentTreatments vary depending on the severity of the diagnosis. A steroid regimen taken orally, often at low doses, is recommended as a first course of treatment. The low dose of steroids can help decrease inflammation, and as a result, lessens the visual impairment. In the event steroids are not effective, medicines may be administered via injections directly into the eye. One such treatment uses Ozurdex. A small capsule is inserted into the eye via injection, and releases medicines slowly, in the course of a few months, as the capsule dissolves. ReferencesFurther reading
|